Earnings Ahead

MRK - Merck

131.08 4.08 3.21

Merck

Merck

About

Profile

Our corporate responsibility approach is aligned with our company’s focus on invention, and underscores our commitment to overcoming the greatest obstacles to health and well-being, developing and rewarding our employees, protecting the environment, and


Headquarters

Kenilworth, New Jersey, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

MRK

The pharmaceutical giant added 2.1% on stronger-than-expected earnings for the first quarter. Merck earned an adjusted $2.07 per share on $15.78 billion in revenue. Analysts surveyed by LSEG forecast $1.88 in earnings per share and $15.20 billion in revenue.


 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Merck trades higher as Keytruda, Gardasil drive Q1 growth amid COVID pill decline
  • Merck Non-GAAP EPS of $1.40 beats by $0.03, revenue of $14.48B beats by $660M
  • Democratic senators introduce bill to enhance CMS drug price negotiations
  • Pfizer, BioNTech hit new 52-week lows
  • Merck, AstraZeneca dip as FDA reviews cancer drug ahead of AdCom meeting
  • Will the Keytruda wave buoy Merck's Q1 results once again?
  • EU publishes proposed reforms for pharma industry
  • Bipartisan agreement reached in Senate prescription drug price legislation
  • What is behind biotech M&A resurgence?
  • Catalyst watch: Earnings blitz, Mobileye lockup expiration and the new one-day VIX debut
  • Earnings Week Ahead: Amazon, Meta Platforms, Alphabet, Coca-Cola, Boeing, and more
  • Prometheus soars 70%, Merck dips after ~$11B buyout deal
  • Prometheus Biosciences had other bidders besides Merck - report
  • Moderna, Merck post detailed Phase 2 data for mRNA cancer shot in melanoma
  • Merck inks ~$11B all-cash deal to acquire Prometheus
  • Merck said to be close to acquiring Prometheus Biosciences - WSJ
  • Ghana 1st in world to approve new malaria vaccine by Oxford
  • Hot Stocks: PGR drops on earnings; CNSL rises on buyout offer; MRK higher on analyst upgrade; EDIT gains; HOG slides
  • Merck upgraded at Citi despite Keytruda patent cliff
  • Merck's Keytruda combo gets FDA review for initial therapy in gastric, esophagus cancer

Earnings History

Date EPS / Forecast Revenue / Forecast
February 3, 2022 1.8 / 1.52 13.52B / 13.14B Beat!
October 28, 2021 1.75 / 1.55 13.15B / 12.32B Beat!
July 29, 2021 1.31 / 1.31 11.4B / 11.08B Beat!
April 29, 2021 1.33 / 1.53 12.08B / 12.61B
February 4, 2021 1.32 / 1.38 12.51B / 12.67B
October 27, 2020 1.74 / 1.44 12.55B / 12.21B Beat!
July 31, 2020 1.37 / 1.06 10.87B / 10.4B Beat!
April 28, 2020 1.5 / 1.34 12.06B / 11.48B Beat!
February 5, 2020 1.16 / 1.15 11.87B / 11.98B
October 29, 2019 1.51 / 1.24 12.4B / 11.64B Beat!
July 30, 2019 1.3 / 1.16 11.76B / 10.96B Beat!
April 30, 2019 1.22 / 1.05 10.82B / 10.47B Beat!
February 1, 2019 1.04 / 1.04 11B / 10.94B Beat!
October 25, 2018 1.19 / 1.14 10.79B / 10.89B
July 27, 2018 1.06 / 1.03 10.47B / 10.28B Beat!
May 1, 2018 1.05 / 1 10.04B / 10.09B
February 2, 2018 0.98 / 0.94 10.43B / 10,494M
October 27, 2017 1.11 / 1.03 10.33B / 10,545M
July 28, 2017 1.01 / 0.87 9.93B / 9,746M Beat!
May 2, 2017 0.88 / 0.83 9.43B / 9,250M Beat!
Date Price Open High Low Vol Change
Apr 18 125.2 125.45
125.45
124.55
3.4M -0.15%
Apr 17 125.39 125.59
126.19
124.72
4.8M 0.26%
Apr 16 125.06 126.5
126.56
125.05
3.9M -0.86%
Apr 15 126.14 126.81
127.81
125.88
5.0M 0.32%
Apr 12 125.74 126.27
126.71
125.11
4.4M -0.31%
 
Apr 11 126.13 126.63
127.14
125.49
3.9M -0.49%
Apr 10 126.75 125.83
126.99
125.07
5.7M 0.03%
Apr 9 126.71 126.62
126.98
125.53
4.7M 0.07%
Apr 8 126.62 127.69
127.91
125.88
4.9M -1.07%
Apr 5 127.99 127.35
128.6
127
5.7M 0.26%
Apr 4 127.66 130.83
130.94
127.34
6.8M -1.72%
Apr 3 129.9 130.63
132.3
129.43
7.7M -0.35%
Apr 2 130.35 130.58
130.67
129.28
6.6M -0.49%
Apr 1 130.99 131.59
131.9
130.11
5.1M -0.73%
Mar 28 131.95 131.94
132.4
131.08
10.2M 0.15%
Mar 27 131.75 132.91
132.96
130.11
16.0M 4.96%
Mar 26 125.52 125.91
126.08
124.87
8.5M 0.17%
Mar 25 125.31 124.08
125.57
123.85
7.6M 1.13%
Mar 22 123.91 123.4
124.48
123.3
4.5M 0.27%
Mar 21 123.58 123.55
124.18
123.06
4.4M -0.22%
Mar 20 123.85 121.28
123.91
120.38
9.8M 1.35%
Mar 19 122.2 121.44
122.26
120.43
10.1M 0.63%
Mar 18 121.44 121.85
122.51
121.13
7.9M -0.07%
Mar 15 121.52 119.84
121.94
119.23
46.1M 0.84%
Mar 14 120.51 121.32
121.32
119.66
10.0M -1.35%
Mar 13 122.16 123.16
123.21
120.8
9.0M -0.41%
Mar 12 122.66 123
123.21
121.43
9.4M -0.09%
Mar 11 122.77 124.65
124.65
121.84
7.8M -0.59%
Mar 8 123.5 123.23
124.04
122.06
9.8M -0.4%
Mar 7 123.99 123.36
124.53
122.82
8.6M 0.19%
Mar 6 123.75 122.84
124.76
122.51
8.2M 0.75%
Mar 5 122.83 124.68
125.04
122.39
8.0M -0.98%
Mar 4 124.05 124.46
126.54
123.29
12.3M -2.29%
Mar 1 126.96 126.87
127.85
126.42
6.0M -0.15%
Feb 29 127.15 128.1
128.85
127.06
11.2M -0.81%
Feb 28 128.19 129.34
129.4
127.7
5.4M -0.65%
Feb 27 129.03 128.26
129.16
127.8
4.6M 0.15%
Feb 26 128.84 129.38
129.7
128.47
5.1M -0.47%
Feb 23 129.45 129.79
130.24
128.86
5.2M 0.15%
Feb 22 129.26 128.15
129.72
127.65
6.4M 0.89%
Feb 21 128.12 127.44
128.16
126.8
4.8M 0.59%
Feb 20 127.37 128.13
129.29
127.21
7.0M -0.33%
Feb 16 127.79 126.5
128.09
126.17
6.3M 0.99%
Feb 15 126.54 125.97
127.23
125.95
5.7M 0.57%
Feb 14 125.82 125.61
126.03
124.82
6.0M 0.31%
Feb 13 125.43 125.98
126.86
124.48
7.1M 0.07%
Feb 12 125.34 125
125.48
124.4
5.1M -0.09%
Feb 9 125.45 126.22
126.69
125.04
7.9M -0.92%
Feb 8 126.61 127.32
127.48
125.94
6.3M -0.67%
Feb 7 127.47 126.9
128.06
126.5
6.7M 0.47%
Feb 6 126.88 126.61
127.52
126.07
6.2M 0.55%
Feb 5 126.18 126.98
127.8
125.7
7.5M -0.18%
Feb 2 126.41 126.71
127.56
126.11
10.2M 0.02%
Feb 1 126.38 123.65
126.43
122.77
11.5M 4.64%
Jan 31 120.78 122.53
122.85
120.5
10.8M -0.72%
Jan 30 121.66 121.28
121.76
120.18
7.4M 0.31%
Jan 29 121.28 121.35
121.46
120.49
9.1M 0.38%
Jan 26 120.82 120.51
121.02
120.08
8.3M 0.57%
Jan 25 120.13 118.66
120.18
118.66
6.7M 1.05%
Jan 24 118.88 119.7
119.95
118.44
5.9M 0%